- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Improving Clinical Outcomes with the Use of Doxycycline in Dengue and Malaria - An Indian Experience

Dengue and Malaria are major public health diseases in India. In the setting of an ongoing pandemic concurring with monsoons in many parts of the country, there will be an ever-increasing burden and challenge of managing both these infections in primary care settings. The scope and therapeutic potential of oral doxycycline in both dengue and malaria are worthy of a review to bring out its clinical application in real-world practice settings.
The above article has been published by Medical Dialogues under the MD Brand Connect Initiative. For more details on Doxycycline, click HERE
Dr.Syed Bahavudeen Hussaini, MBBS, MD, DNB, FICP, is a practising physician with experience of more than 20 years and is currently working as an Associate professor of Medicine Government Theni Medical College. He is also a Fellow of the Indian College of Physicians and has presented many papers at National and State Conferences. His interest lies in recent advances in Medicine.